The Journal of Organic Chemistry
Article
1
(28.6 mg), Rf = 0.4 (EtOAc/petroleum ether 1:5). H NMR (500
MHz, CDCl3): δ 7.09 (dd, J1 = 8.5 Hz, J2 = 1.4 Hz, 1H), 6.85 (d, J =
8.5 Hz, 1H), 6.56 (d, J = 1.0 Hz, 1H), 6.50 (dd, J1 = 5.9 Hz, J2 = 2.4
Hz, 2H), 6.13−6.10 (m, 2H), 3.33 (s, 3H), 3.26 (t, J = 2.4 Hz, 2H).
13C{1H} NMR (125 MHz, CDCl3): δ 178.9, 144.0, 143.9, 143.2,
7′-Bromo-1′-methylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-
2,4-dien-2′-one (3p). Procedure A, white solid, 69% yield (20.8 mg),
Rf = 0.3 (EtOAc/petroleum ether 1:5). 1H NMR (400 MHz, CDCl3):
δ 7.32 (d, J = 8.2 Hz, 1H), 6.73 (t, J = 7.9 Hz, 1H), 6.58 (d, J = 7.6
Hz, 1H), 6.49 (dd, J1 = 7.5 Hz, J2 = 2.5 Hz, 2H), 6.11−6.09 (m, 2H),
3.73 (s, 3H), 3.25 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ
179.6, 141.7, 131.8, 129.2, 126.7, 123.9, 122.6, 121.6, 102.0, 42.1,
30.8, 14.9. HRMS (ESI) m/z: calcd for C15H13BrNO [M + H]+
302.0175, found 302.0174.
127.2, 126.4, 123.8, 118.9, 116.9, 107.4, 40.9, 27.1, 15.4. HRMS (ESI)
m/z: calcd for C16H13F3NO2 [M + H]+ 308.0893, found 308.0895.
1′-Methyl-5′-nitrospiro[bicyclo[4.1.0]heptane-7,3′-indoline]-2,4-
dien-2′-one (3i). Procedure A, yellow solid, 70% yield (18.8 mg), Rf =
1
1′,3-Dimethylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-2,4-
0.4 (EtOAc/petroleum ether 1:5). H NMR (400 MHz, CDCl3): δ
dien-2′-one (3t). Procedure A, colorless oil, 88% yield (20.9 mg), Rf =
8.20 (dd, J1 = 8.6 Hz, J2 = 2.2 Hz, 1H), 7.49 (d, J = 2.1 Hz, 1H), 6.94
(d, J = 8.6 Hz, 1H), 6.62 (dd, J1 = 7.4 Hz, J2 = 2.8 Hz, 2H), 6.18−6.14
(m, 2H), 3.39 (s, 3H), 3.34 (t, J = 2.8 Hz, 2H). 13C{1H} NMR (75
MHz, CDCl3): δ 179.4, 150.1, 142.7, 127.1, 126.3, 123.7, 123.4,
118.5, 106.8, 41.2, 27.4, 15.2. HRMS (ESI) m/z: calcd for
C15H13N2O3 [M + H]+ 269.0921, found 269.0913.
6′-Chloro-1′-methylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-
2,4-dien-2′-one (3j). Procedure A, red solid, 90% yield (23.2 mg), Rf
= 0.3 (EtOAc/petroleum ether 1:5). 1H NMR (500 MHz, CDCl3): δ
6.87 (td, J1 = 9.2 Hz, J2 = 2.3 Hz, 2H), 6.56 (d, J = 8.08 Hz, 1H), 6.47
(dd, J1 = 9.2 Hz, J2 = 3.6 Hz, 2H), 6.13−6.08 (m, 2H), 3.30 (s, 3H),
3.22 (t, J = 3.8 Hz, 2H). 13C{1H} NMR (125 MHz, CDCl3): δ 179.2,
145.8, 132.4, 126.3, 124.4, 123.9, 123.6, 121.3, 108.3, 41.1, 27.1, 15.8.
HRMS (ESI) m/z: calcd for C15H12ClNNaO [M + Na]+ 280.0500,
found 280.0504.
6′-Bromo-1′-methylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-
2,4-dien-2′-one (3k). Procedure A, white solid, 81% yield (24.5 mg),
Rf = 0.3 (EtOAc/petroleum ether 1:5). 1H NMR (400 MHz, CDCl3):
δ 7.02 (d, J = 11.0 Hz, 2H), 6.48 (t, J = 9.7 Hz, 3H), 6.10 (d, J = 4.0
Hz, 2H), 3.30 (s, 3H), 3.22 (s, 2H). 13C{1H} NMR (100 MHz,
CDCl3): δ 178.9, 145.9, 126.3, 124.9, 124.2, 124.0, 123.9, 120.2,
111.0, 40.9, 27.1, 15.7. HRMS (ESI) m/z: calcd for C15H13BrNO [M
+ H]+ 302.0174, found 302.0173.
1
0.3 (EtOAc/petroleum ether 1:5), regioisomer ratio 2:1. H NMR
(500 MHz, CDCl3): δ 7.22 (td, J1 = 7.8 Hz, J2 = 1.2 Hz, 1H), 6.93−
6.89 (m, 3H), 6.66 (d, J = 7.4 Hz, 1H), 6.50 (dd, J1 = 8.0 Hz, J2 = 1.1
Hz, 0.5H), 6.4 (dd, J1 = 9.4 Hz, J2 = 6.1 Hz, 1H), 6.33 (dd, J1 = 9.5
Hz, J2 = 1.1 Hz, 0.5H), 6.24 (d, J = 6 Hz, 1H), 6.09 (dd, J1 = 9.4 Hz,
J2 = 5.1 Hz, 0.5H), 5.94 (dd, J1 = 9.3 Hz, J2 = 5.4 Hz, 1H), 5.83−5.82
(m, 0.5 H), 3.34 (s, 3H), 3.32 (s, 1.5H). 13C{1H} NMR (125 MHz,
CDCl3): δ 179.4, 179.0, 144.6, 144.5, 134.3, 133.6, 130.1, 126.9,
126.2, 126.1, 126.0, 125.6, 124.0, 122.6, 122.5, 121.7, 121.6, 121.5,
120.6, 119.1, 107.6, 107.5, 41.8, 40.3, 40.0, 39.3, 27.0, 26.9, 23.7, 21.8,
17.5, 16.2. HRMS (ESI) m/z: calcd for C16H15NNaO [M + Na]+
260.1046, found 260.1061.
1′,2,3-Trimethylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-2,4-
dien-2′-one (3u). Procedure A, white solid, 77% yield (19.4 mg), Rf =
1
0.3 (EtOAc/petroleum ether 1:5), regioisomer ratio 3:1. H NMR
(400 MHz, CDCl3): δ 7.21 (t, J = 7.7 Hz, 1.3H), 6.91−6.88 (m,
2.7H), 6.46 (d, J = 7.5 Hz, 1H), 6.34 (d, J = 7.4 Hz, 0.3H), 6.30 (d, J
= 9.4 Hz, 1H), 5.92−5.86 (m, 1.6H), 3.33 (s, 3H), 3.32 (s, 1H),
3.15−3.12 (m, 1.6H), 3.06 (d, J = 8.7 Hz, 1H), 2.03 (s, 2H), 1.99 (s,
3H), 1.82 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 179.3,
179.1, 144.6, 144.5, 136.1, 132.0, 127.7, 126.6, 126.3, 125.8, 122.3,
122.2, 121.5, 121.4, 120.4, 107.6, 107.5, 43.1, 39.9, 39.4, 26.9, 20.0,
19.9, 18.4, 17.8, 17.6. HRMS (ESI) m/z: calcd for C17H18NO [M +
H]+ 252.1383, found 252.1384.
1′,7′-Dimethylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-2,4-
dien-2′-one (3l). Procedure A, red solid, 90% yield (21.4 mg), Rf =
1′,2,5-Trimethylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-2,4-
1
0.3 (EtOAc/petroleum ether 1:5). H NMR (400 MHz, CDCl3): δ
dien-2′-one (3v). Procedure A, red solid, 64% yield (16.1 mg), Rf =
1
6.95 (d, J = 7.7 Hz, 1H), 6.79 (t, J = 7.7 Hz, 1H), 6.55 (d, J = 7.4 Hz,
1H), 6.47 (dd, J1 = 7.3 Hz, J2 = 2.9 Hz, 2H), 6.12−6.06 (m, 2H), 3.62
(s, 3H), 3.22 (dd, J1 = 3.6 Hz, J2 = 2.6 Hz, 2H), 2.62 (s, 3H). 13C{1H}
NMR (100 MHz, CDCl3): δ 179.9, 142.4, 130.1, 126.9, 126.4, 124.0,
121.4, 120.7, 119.2, 42.5, 30.6, 19.5, 15.2. HRMS (ESI) m/z: calcd for
C16H16NO [M + H]+ 238.1227, found 238.1228.
0.4 (EtOAc/petroleum ether 1:5). H NMR (400 MHz, CDCl3): δ
7.21 (td, J1 = 7.7 Hz, J2 = 0.8 Hz, 1H), 6.92−6.87 (m, 2H), 6.63 (d, J
= 7.5 Hz, 1H), 6.2 (s, 2H), 3.84 (s, 3H), 3.01 (s, 2H), 1.84 (s, 6H).
13C{1H} NMR (125 MHz, CDCl3): δ 179.6, 144.4, 130.1, 125.9,
125.3, 122.4, 122.3, 121.6, 107.5, 42.5, 27.0, 23.2, 17.0. HRMS (ESI)
m/z: calcd for C17H18NO [M + H]+ 252.1383, found 252.1385.
3-(tert-Butyl) 1′-Methylspiro[bicyclo[4.1.0]heptane-7,3′-indo-
line]-2,4-dien-2′-one (3w). Procedure A, colorless oil, 85% yield
(23.7 mg), Rf = 0.3 (EtOAc/petroleum ether 1:5), regioisomer ratio
7′-Chloro-1′-methylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-
2,4-dien-2′-one (3m). Procedure A, yellow solid, 69% yield (17.8
1
mg), Rf = 0.3 (EtOAc/petroleum ether 1:5). H NMR (400 MHz,
1
CDCl3): δ 7.14 (d, J = 8.2 Hz, 1H), 6.79 (t, J = 7.9 Hz, 1H), 6.55 (d, J
= 7.6 Hz, 1H), 6.49 (dd, J1 = 7.4 Hz, J2 = 2.9 Hz, 2H), 6.12−6.09 (m,
2H), 3.71 (s, 3H), 3.24 (t, J = 3.0 Hz, 2H). 13C{1H} NMR (100
MHz, CDCl3): δ 179.4, 140.3, 128.8, 128.5, 126.6, 123.9, 122.1,
121.1, 115.1, 42.0, 30.5, 15.1. HRMS (ESI) m/z: calcd for
C15H13ClNO [M + H]+ 258.0680, found 258.0681.
1′-Methyl-7′-nitrospiro[bicyclo[4.1.0]heptane-7,3′-indoline]-2,4-
dien-2′-one (3n). Procedure A, colorless oil, 92% yield (24.7 mg), Rf
= 0.4 (EtOAc/petroleum ether 1:5). 1H NMR (400 MHz, CDCl3): δ
7.55 (d, J = 8.2 Hz, 1H), 6.93 (t, J = 8.0 Hz, 1H), 6.79 (d, J = 7.2 Hz,
1H), 6.53 (dd, J1 = 7.4 Hz, J2 = 2.4 Hz, 2H), 6.16−6.12 (m, 2H), 3.23
(s, 3H), 3.32−3.28 (m, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ
179.74, 138.0, 135.1, 129.5, 126.9, 126.2, 123.9, 121.7, 121.0, 41.9,
30.5, 14.3. HRMS (ESI) m/z: calcd for C15H13N2O3 [M + H]+
269.0921, found 269.0920.
1.5:1. H NMR (400 MHz, CDCl3): δ 7.26−7.18 (m, 2.5H), 6.91−
6.86 (m, 5H), 6.64−6.60 (m, 2.5H), 6.55 (d, J = 7.4 Hz, 1H), 6.44
(dd, J1 = 9.2 Hz, J2 = 6.3 Hz, 1.5H), 6.28 (d, J = 6.3 Hz, 1.5H), 6.12
(dd, J1 = 9.8 Hz, J2 = 5.1 Hz, 1H), 5.92 (dd, J1 = 9.2 Hz, J2 = 5.0 Hz,
1.5H), 5.88 (d, J = 5.5 Hz, 1H), 3.34 (s, 4.5H), 3.32 (s, 3H), 3.24−
3.21 (m, 2H), 3.20−3.11 (m, 3H), 1.21 (s, 9H), 0.96 (s, 14H).
13C{1H} NMR (100 MHz, CDCl3): δ 179.4, 179.0, 146.3, 144.6,
146.4, 144.3, 127.2, 127.1, 126.2, 125.9, 125.8, 123.9, 122.9, 122.6,
121.5, 121.1, 120.9, 117.6, 115.3, 107.5, 107.4, 39.6, 38.4, 35.8, 34.8,
29.3, 28.0, 27.0, 26.9, 16.9, 16.5. HRMS (ESI) m/z: calcd for
C19H21NNaO [M + Na]+ 302.1515, found 302.1520.
3-Fluoro-1′-methylspiro[bicyclo[4.1.0]heptane-7,3′-indoline]-
2,4-dien-2′-one (3x). Procedure A, colorless oil, 86% yield (20.7 mg),
Rf = 0.3 (EtOAc/petroleum ether 1:5), regioisomer ratio 1:1. 1H
NMR (500 MHz, CDCl3): δ 7.28−7.24 (m, 2H), 6.97−6.91 (m, 4H),
6.75 (dd, J1 = 7.2 Hz, J2 = 5.2 Hz, 2H), 6.44−6.37 (m, 2H), 6.25−
6.26 (m, 1H), 6.06−6.02 (m, 1H), 5.89 (dd, J1 = 9.3 Hz, J2 = 5.2 Hz,
1H), 5.68−5.65 (m, 1H), 3.40−3.34 (m, 2H), 3.33 (s, 3H), 3.31 (s,
3H), 3.29−3.22 (m, 2H). 13C{1H} NMR (125 MHz, CDCl3): δ
178.4, 177.9, 160.5, 159.6, 158.6, 157.5, 144.6, 144.4, 128.0, 127.9,
126.8, 126.3, 126.2, 126.1, 125.5, 122.7, 122.6, 122.2, 122.0, 121.9,
121.4, 121.1, 119.3, 119.2, 1183, 108.7, 107.9, 103.9, 103.8, 102.5,
102.3, 27.1, 26.9. HRMS (ESI) m/z: calcd for C15H12FNNaO [M +
Na]+ 264.0795, found 264.0797.
1′-Methyl-7′-(trifluoromethyl)spiro[bicyclo[4.1.0]heptane-7,3′-
indoline]-2,4-dien-2′-one (3o). Procedure A, red solid, 83% yield
1
(24.2 mg), Rf = 0.3 (EtOAc/petroleum ether 1:5). H NMR (400
MHz, CDCl3): δ 7.49 (d, J = 8.1 Hz, 1H), 6.95 (t, J = 7.9 Hz, 1H),
6.82 (d, J = 7.6 Hz, 1H), 6.52 (dd, J1 = 7.4 Hz, J2 = 2.8 Hz, 2H),
6.15−6.12 (m, 2H), 3.54 (d, J = 2.2 Hz, 3H), 3.28 (t, J = 2.9 Hz, 2H).
13C{1H} NMR (100 MHz, CDCl3): δ 179.9, 128.5, 126.8, 125.9,
124.0, 123.8, 123.7, 120.7, 112.1, 42.2, 29.8, 29.7, 13.9. HRMS (ESI)
m/z: calcd for C16H13F3NO [M + H]+ 292.0944, found 292.0945.
G
J. Org. Chem. XXXX, XXX, XXX−XXX